-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Maintains Buy on cbdMD, Lowers Price Target to $2

Benzinga·08/20/2025 13:10:51
Listen to the news
Maxim Group analyst Tom McGovern maintains cbdMD (AMEX:YCBD) with a Buy and lowers the price target from $3 to $2.